Document:

Translation of Management Fee Agreement, dated February 17, 2010

 Exhibit 10.13 

[Translation from Hebrew] 

Management Fee Agreement 

Entered into and signed in Ramat Gan on February 17, 2010 

 

					
	By and among::	  	D. Medical Industries Ltd.	  	
		  	Public Company No. 520041955	  	
		  	7 Jabutinsky St., Ramat Gan	  	
		  	(hereinafter: “D Medical”)	  	On the first side
			
	And	  	Medx-Set Ltd.	  	
		  	Private Company No. 514090257	  	
		  	3 H’sadna St., Tirat Ha’carmel	  	
		  	(hereinafter: “Medx-Set”)	  	On the second side

  

			
	Whereas	 	Some of D Medical’s employees extend during their current employment certain management services to Medx-Set (hereinafter “Management
Services”);
		
	and Whereas	 	Medx-Set is interested in receiving from D Medical’s abovementioned employees the Management Services;
		
	and Whereas	 	D Medical declares that it has the human resources, the knowledge, the experience, the qualifications and the professional ability in order to extend to Medx-Set the Management
Services;
		
	and Whereas	 	D Medical and Medx-Set desire to determine the payment for the Management Services;

Now therefore, the parties agree as follows: 

 

	19.	Preamble and Interpretation 

  

			
	19.1.	  	The preamble to this agreement constitute an integral part hereof and shall be read in conjunction with its other provisions.
		
	19.2.	  	The headings of the sections in this agreement are for convenience only and shall not be given any weight for the purpose of interpretation.
		
	19.3.	  	No change, amendment, addition or deletion shall be valid after signing of this agreement unless made in writing and signed by all parties.

			
	19.4.	  	No provision of this agreement derogates from any other provision of this agreement, rather to add thereon, unless otherwise provided in this agreement.
		
	19.5.	  	Any provision or expression in singular shall refer to plural also and vice versa and any masculine shall include feminine and vice versa and referring to a person shall include
an entity also and vice versa.
		
	19.6.	  	All exhibits to this agreement shall constitute and integral part hereof.

  

	20.	D Medical’s Representations  

Upon signing this agreement, D Medical represents as follows: 

 

			
	20.1.	  	This agreement and the execution of D Medical’s undertakings do not constitute a breach or are inconsistent with D Medical’s articles of association, any agreement
which D Medical is a party, and/or to any obligation by D Medical, whether by an agreement or by law, and there is no legal or any other prevention to its engagement in this agreement and to the execution of its undertaking according to this
agreement.
		
	20.2.	  	D Medical has the human resources, the ability, the skill and the experience required, and it has all means, financial and others, in order to execute its undertakings according
to this agreement.

  

	21.	Medx-Set Representations  

Upon signing this agreement, Medx-Set represents as follows: 

 

			
	21.1.	  	This agreement and execution of Medx-Set undertakings do not constitute a breach or inconsistent with Medx-Set’s articles of association, an agreement which Medx-Set is a
party, and/or to any obligation by Medx-Set, whether by an agreement or by law, and there is no legal or any other prevention to its engagement in this agreement and to the execution of its undertaking according to this agreement.
		
	21.2.	  	Medx-Set has all means, financial and others, in order to execute its undertakings according to this agreement.

 

	22.	Providing Management Services  

  

					
	22.1.	  	As of November 1, 2009, (hereinafter: “Commencement Date of Providing Services”) D Medical provided and will provide to Medx-Set the Management
Services. D Medical is providing and will provide the Management Services in dedication and efficiency and in a professional manner. Without derogating form the generality of the aforesaid, the Management Services shall include, among
others:
			
		  	22.1.1.	  	Management Services through the chief executive officer of D Medical;

	 	

			
	22.1.2.	    	Financial services through the chief financial officer of D Medical;
		
	22.1.3.	    	Business development services through the business development officer of D Medical;
		
	22.1.4.	    	Office space to the abovementioned employees in D Medical’s offices in Ramat Gan;
		
	22.1.5.	    	Participation in current expenses and ancillary services.

  

	23.	The Consideration 

  

			
	23.1.	  	As Consideration for the Management Services extended by D Medical to Medx-Set, Medx-Set is paying to D Medical, as of the Commencement Date of Providing Services a monthly
consideration in the sum of NIS 50,000, plus VAT as applicable by law (hereinafter: “Management Fees”).
		
	23.2.	  	The payment for the Management Services shall be made against written evidence as required by law for the payment, plus VAT by law, if and to the extent that VAT will be charged
on the Management Services.
		
	23.3.	  	The consideration shall be paid to D Medical once every month, not later than the
9th day of every month, for Management Services provided
by D Medical to Medx-Set in the previous month.

  

	24.	The Term of the Agreement 

  

			
	24.1.	  	This agreement shall be effective as of the Commencement Date of Providing Services and shall remain in force for an unlimited period.
		
	24.2.	  	Each party may terminate this agreement by furnishing a written notice to the other party, subject to a 90 days prior written notice.

 

	25.	Approvals 

 Each
party to this agreement undertakes to receive all required approvals according to any law for the purpose of engaging in this agreement. 

	26.	Nature of Relations of D Medical and Medx-Set 

D Medical is an independent contractor for executing its obligations according to this agreement, and no employee-employer relations are
or will exist between the parties and/or between Medx-Set and/or on its behalf, and D Medical and/or on its behalf, and the provisions of this agreement do not constitute employee-employer relations by any means between D Medical and/or any of its
employees and Medx-Set and/or any of its employees. 
  

	27.	Notices 

  

			
	27.1.	  	Notice that will be delivered according to the parties’ addresses as detailed in the preamble to this agreement in registered mail shall be considered as received by the
addressee within 72 hours from its sending. If such notice is delivered by hand, it will be considered as received on the date of delivery.
		
	27.2.	  	Each party may change its address for the purpose of this agreement to another address in Israel by a written notice which shall be delivered to the other party in the said
address.
		
	27.3.	  	It is agreed that this Agreement shall be governed by laws of the State of Israel. The parties agree that any dispute arising under or in relation to this agreement shall be
resolved exclusively by the competent court in Tel Aviv-Jaffa.

 IN WITNESS WHEREOF, each of the Parties has signed this agreement
as of the date first hereinabove set forth. 
  

					
	 [signature]
	 		  	 [signature]

	 D. Medical Industries Ltd.
	 		  	Medx-Set Ltd.Translation of Loan Agreement, dated September 13, 2009

 Exhibit 10.14 

[Translation from Hebrew] 

Loan Agreement 

Made and entered into in Ramat-Gan on 13 of September, 2009 

 

					
	By and among:	  	D. Medical Industries Ltd.	  	
		  	Of 7 Jabotinsky Street	  	
		  	Ramat Gan	  	
		  	(Hereinafter: the “Company”)	  	On the first side;
			
	And	  	Nilimedix Ltd.	  	
		  	From MATAM Center of Science Industries
		  	(Hereinafter: “Nilimedix”)	  	On the second side;

 WHEREAS,
Nilimedix approached the Company in a request for a loan in the amount of NIS 2,629,900, that will be linked to the CPI and will bear an annual interest of 4%, for an unlimited period and up until 5 years from the date of the grant of the loan; and

 WHEREAS, the Company was willing to grant the loan to Nilimedix; 

NOW, THEREFORE, IT HAS BEEN PROVIDED AND AGREED AMONG 

THE PARTIES AS FOLLOWS: 
  

	1.	Preamble, declarations and headings 

  

	 	1.1	The preamble to this agreement, its parties’ representations and its attached annexes form an integral part hereof. 

 

	 	1.2	This agreement’s division into sections and annexes and the headings appearing herein were made for convenience purposes and may not be used for its
interpretation. 

  

	2.	The Loan 

  

	 	2.1	Subject to what is stated in this agreement, the Company will lend Nilimedix a loan in the sum of NIS 2,629,900 (hereinafter: “The Loan”).

  

	 	2.2	The Loan will be linked to the CPI (whereas on the date of repayment of the Loan, the ratio between the known index at the time of the repayment of the Loan and the
known index on the date of grant of the Loan and the balance of the principal and interest will be revalued) and will bear an annual interest at the rate of 4%. For avoidance of doubt it is clarified that the principal amount of the Loan together
with linkage differentials and interest will be paid at the end of the Loan term. 

  

	 	2.3	The Loan will be for an unlimited period and up until 5 years commencing as of the date of grant of the Loan. Upon the lapse of a year following the date of execution
of this agreement, the Company will be able to demand from Nilimedix immediate repayment of the loan, and Nilimedix shall be obligated to repay, within 90 days of the aforesaid demand, the unpaid balance of the Loan (Principal + interest + linkage
differentials). 

 [Translation from Hebrew] 
  

	3.	General 

  

	 	3.1	This agreement fully reflects the parties’ agreements, and cancels all representations, understandings or agreements that have been made, if any, before signing
this agreement. 

  

	 	3.2	The parties undertake to be faithful and honest, one towards the other. 

  

	 	3.3	The Tel-Aviv-Jaffa courts shall have exclusive jurisdiction regarding the execution of this agreement and the undertakings under it. 

 

	 	3.4	Any addendum and/or amendment to this agreement will not be valid unless made in writing and signed by the parties. 

 

	 	3.5	The parties’ addresses for this agreement’s purposes will be determined by the parties, as detailed in the aforesaid preamble. Any notice that will be sent
from one party to the other in registered mail according to his address will be considered as if it reached its destination within 72 hours from the time it was given to the mail delivery, or if delivered by hand and/or by fax and/or any other
instrument for message delivery – upon delivery. 

 In witness whereof, the undersigned parties have signed

  

					
	 [signature]
	  		  	 [signature]

	The Company	  		  	Nilimedix Ltd.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]